Skip to content

DR. VANWULPEN

Active Private limited companyfounded 2001active for 25 yearsLeopold III-laan 2/0905, 8400 OstendKBO/BCE: BE 0474.093.438

Lifetime

20 annual accounts with figures on one time axis, 25 filings since 2001
peak of €444,915 in 2019
€219,095▼ 12.3%
lowest -€59,032 in 2016
€84,840▼ 18.5%
peak of €1.5m in 2024
€1.5munchanged
€439,227▲ 6.8%
Board3 names since 2001
1 director
Documentsfilings and deeds
28-07-20263 days before the deadline
2025micro format
Gross margin from €249,784 to €219,095Dividend €84,935Cash from €76,495 to €176,451

Key points

from the 2025 annual accounts

Equity

€1.5m =
1.52024+0.08Profit-0.08Dividend1.52025

DR. VANWULPEN paid out €84,935 in dividends. That is 100% of the 2025 profit.

Filings

25 annual accounts since 2001
AprilJune31 JulyOctober20102020

Six of the last ten came late. The 2020 accounts came in latest, 61 days after the end of the period.

Position in the sector

€1.5m

More equity than 95% of companies in human health. Sector median €125,088 · 21,349 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 14,774 companies had the same profile as DR. VANWULPEN has now. Each dot stands for 37 companies, two years later.

96.1%
were still trading
3.5%
stopped another way
0.2%
went bankrupt
  • Small
  • 20 years or older
  • solvency 30% or more
  • a profit under 5% of the balance sheet

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 14,774 companies, not a prediction for DR. VANWULPEN. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Manager
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0474093438
Registered office moved to Ostend The registered office moved to Leopold III laan 2/0905, 8400 Oostende · (successor statutory director) and (statutory director) appointed · General meeting of 21-12-2023 · Gazette deed
appointed as statutory manager Gazette deed
Incorporation published on 28-02-2001 · Gazette deed
All 40 events

Comparable companies

same main activity, similar in size and age
Company
DR. VANWULPEN Ostend €1.9m €219,095 77.4% -
KARAR MEDICAL Brussels €2.2m €206,785 4.9% -
MEDICAL EUROPE CONSULT Fosses-la-Ville €1.7m €242,117 46.0% -
DR. DE NEVE P. Ostend €1.7m €197,499 97.9% -
DR. KOEN MELIS Knokke-Heist €1.8m €187,851 83.4% -
DOKTER D. VERHULST Knokke-Heist €1.6m €195,509 83.3% -
Dokter Ann Lechat Koksijde €1.8m €263,221 65.3% -

These companies have the same main activity as DR. VANWULPEN: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1.6m and €2.2m, founded between 1999 and 2005.

Official details

Source: KBO
Status
Active since 16-02-2001Normal situation
Registered office
17 active companies are registered at this address3 started in the 12 months before. Source: KBO register, as of 18 November 2026.
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.303.645.5758400 Ostend, since 16-02-2001
Financial year end
31 December
Peppol
Reachable since 12-11-2025
Company details

Annual accounts 2025

≈ €410,000estimated
€1.9m▲ 1.5%
Filing
Filed on 28-07-2026, 3 days before the end of the filing period
Financials

Insights on DR. VANWULPEN

DR. VANWULPEN files the micro format. That format states no turnover. The gross margin rose from €139,573 in 2006 to €219,095 in 2025.

The balance sheet grew most from 2009 to 2011 through fixed assets, financed with long-term debt.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about DR. VANWULPEN

What is the company number of DR. VANWULPEN?
The company number of DR. VANWULPEN is 0474.093.438. The VAT number is the same number with BE in front: BE 0474.093.438.
Where is DR. VANWULPEN based?
The registered office is at Leopold III-laan 2/0905, 8400 Ostend.Company details
What does DR. VANWULPEN do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. VANWULPEN?
DR. VANWULPEN is a private limited company (BV).
When was DR. VANWULPEN founded?
DR. VANWULPEN was founded on 16-02-2001.
Is DR. VANWULPEN still active?
Yes, DR. VANWULPEN is an active enterprise in the KBO register.
What is the turnover of DR. VANWULPEN?
The turnover in financial year 2025 is ≈ €410,000. This figure is estimated from the gross margin of €219,095 and 40 comparable companies (NACE 86220). It probably lies between €350,000 and €540,000.Financials
Is DR. VANWULPEN profitable?
In financial year 2025, DR. VANWULPEN made a profit of €84,840.
Where can I find the annual accounts of DR. VANWULPEN?
DR. VANWULPEN filed 25 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR. VANWULPEN due?
DR. VANWULPEN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.